uniQure
QURE
#5848
Rank
ยฃ0.81 B
Marketcap
ยฃ13.01
Share price
1.60%
Change (1 day)
72.22%
Change (1 year)

uniQure (QURE) - Cash on Hand

Cash on Hand as of December 2025 : ยฃ0.47 Billion

According to uniQure's latest financial reports the company has ยฃ0.47 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

uniQure - Cash on Hand chart (from 2012 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31ยฃ0.46 B57.84%
2024-12-31ยฃ0.29 B-39.62%
2023-12-31ยฃ0.48 B66.29%
2022-12-31ยฃ0.29 B-29.23%
2021-12-31ยฃ0.41 B129.33%
2020-12-31ยฃ0.17 B-37.63%
2019-12-31ยฃ0.28 B55.69%
2018-12-31ยฃ0.18 B56.93%
2017-12-31ยฃ0.11 B9.82%
2016-12-31ยฃ0.10 B-28.2%
2015-12-31ยฃ0.14 B259.79%
2014-12-31ยฃ41.56 M108.54%
2013-12-31ยฃ19.93 M9162.41%
2012-12-31ยฃ0.21 M-76.54%
2011-12-31ยฃ0.91 M-94.04%
2010-12-31ยฃ15.38 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
ยฃ6.91 B 1,366.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ7.53 B 1,497.71%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
ยฃ22.44 M-95.24%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
ยฃ59.68 M-87.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ1.18 B 150.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
ยฃ1.28 B 172.57%๐Ÿ‡บ๐Ÿ‡ธ USA